This report contains market size and forecasts of Chimeric Antigen Receptor T Cell Therapy in Global, including the following market information:
Global Chimeric Antigen Receptor T Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chimeric Antigen Receptor T Cell Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allogeneic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chimeric Antigen Receptor T Cell Therapy include Amgen, Bellicum Pharmaceuticals, Bluebird Bio, Caribou Biosciences, Celgene Corporation, Cellectis, Celyad Oncology, Gilead Sciences and Intellia Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chimeric Antigen Receptor T Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chimeric Antigen Receptor T Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chimeric Antigen Receptor T Cell Therapy Market Segment Percentages, by Type, 2021 (%)
Allogeneic
Autologous
Global Chimeric Antigen Receptor T Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chimeric Antigen Receptor T Cell Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Universities and Colleges
Others
Global Chimeric Antigen Receptor T Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chimeric Antigen Receptor T Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chimeric Antigen Receptor T Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chimeric Antigen Receptor T Cell Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Bellicum Pharmaceuticals
Bluebird Bio
Caribou Biosciences
Celgene Corporation
Cellectis
Celyad Oncology
Gilead Sciences
Intellia Therapeutics
Johnson & Johnson
Legend Biotech
Merck
Noile-Immune Biotech
Novartis
Pfizer
Sangamo Therapeutics
Servier Laboratories